Literature DB >> 8792600

Systemic lupus erythematosus with nephropathy.

J P Hayslett1, H Carey.   

Abstract

This paper is the first in a new Clinical Feature Series that will be a regular feature in future issues of The Yale Journal of Biology and Medicine. Papers in the series will focus on cases and disease processes of general interest to the practicing clinician, with the goal being to present the perspectives of expert clinicians regarding the accurate diagnosis and effective treatment of the diseases being discussed. The following case was presented at Medical Grand Rounds at the Yale-New Haven Hospital and the Yale School of Medicine by John P. Hayslett, Professor of Medicine (Nephrology) with accompanying analysis of pathological specimens by Dr. Hugh Carey, a Postdoctoral Fellow of the Pathology staff. The patient whose case is presented was also present to describe her experience with the illness and the course of treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8792600      PMCID: PMC2588957     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  9 in total

1.  Prognostic indices in lupus nephritis.

Authors:  B Hecht; N Siegel; M Adler; M Kashgarian; J P Hayslett
Journal:  Medicine (Baltimore)       Date:  1976-03       Impact factor: 1.889

2.  Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population.

Authors:  H Jonsson; O Nived; G Sturfelt
Journal:  Medicine (Baltimore)       Date:  1989-05       Impact factor: 1.889

3.  The pathogenesis and prognosis of lupus nephritis: information from repeat renal biopsy.

Authors:  J M Esdaile; L Joseph; T MacKenzie; M Kashgarian; J P Hayslett
Journal:  Semin Arthritis Rheum       Date:  1993-10       Impact factor: 5.532

Review 4.  Long-term prognosis of diffuse lupus nephritis.

Authors:  C Ponticelli; P Zucchelli; G Moroni; L Cagnoli; G Banfi; S Pasquali
Journal:  Clin Nephrol       Date:  1987-12       Impact factor: 0.975

5.  The effect of systemic lupus erythematosus on pregnancy and pregnancy outcome.

Authors:  J P Hayslett
Journal:  Am J Reprod Immunol       Date:  1992 Oct-Dec       Impact factor: 3.886

6.  Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.

Authors:  H A Austin; J H Klippel; J E Balow; N G le Riche; A D Steinberg; P H Plotz; J L Decker
Journal:  N Engl J Med       Date:  1986-03-06       Impact factor: 91.245

7.  Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only.

Authors:  A D Steinberg; S C Steinberg
Journal:  Arthritis Rheum       Date:  1991-08

Review 8.  The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature.

Authors:  J M Esdaile; C Levinton; W Federgreen; J P Hayslett; M Kashgarian
Journal:  Q J Med       Date:  1989-09

9.  The benefit of early treatment with immunosuppressive agents in lupus nephritis.

Authors:  J M Esdaile; L Joseph; T MacKenzie; M Kashgarian; J P Hayslett
Journal:  J Rheumatol       Date:  1994-11       Impact factor: 4.666

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.